Park Avenue Securities LLC Sells 990 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Park Avenue Securities LLC lowered its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 6.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,165 shares of the company’s stock after selling 990 shares during the period. Park Avenue Securities LLC’s holdings in Privia Health Group were worth $258,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Canada Pension Plan Investment Board acquired a new stake in shares of Privia Health Group in the second quarter valued at approximately $26,000. Nisa Investment Advisors LLC lifted its position in shares of Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after acquiring an additional 930 shares during the period. Signaturefd LLC grew its holdings in shares of Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after purchasing an additional 626 shares in the last quarter. Park Place Capital Corp increased its position in shares of Privia Health Group by 115.4% in the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after purchasing an additional 1,335 shares during the period. Finally, Covestor Ltd raised its stake in Privia Health Group by 25.5% in the first quarter. Covestor Ltd now owns 5,292 shares of the company’s stock valued at $104,000 after purchasing an additional 1,076 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Price Performance

PRVA opened at $17.55 on Monday. The company’s 50 day moving average price is $18.90 and its two-hundred day moving average price is $18.34. The firm has a market capitalization of $2.09 billion, a price-to-earnings ratio of 117.00, a PEG ratio of 3.93 and a beta of 0.76. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $24.35.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The company had revenue of $422.30 million during the quarter, compared to analyst estimates of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The business’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.06 earnings per share. As a group, equities research analysts predict that Privia Health Group, Inc. will post 0.16 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Robert W. Baird raised their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a report on Monday, August 26th. KeyCorp initiated coverage on shares of Privia Health Group in a research report on Friday. They set an “overweight” rating and a $23.00 price objective for the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research note on Wednesday, August 14th. Finally, Evercore ISI lowered their price target on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Two analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $24.73.

Insider Transactions at Privia Health Group

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 14.20% of the stock is owned by corporate insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.